Table 2.
Initial Recurrence after Resection of Perihilar Cholangiocarcinoma
| Site | No. of recurrences |
All 177 patients with a recurrence, %* |
All 306 patients, % |
|---|---|---|---|
| Local | |||
| Liver hilum | 34 | 19 | 11 |
| Hepaticojejunostomy | 23 | 13 | 8 |
| Distal bile duct remnant | 6 | 3 | 2 |
| Liver resection margin | 23 | 13 | 8 |
| Distant | |||
| Liver intrahepatic | 40 | 23 | 13 |
| Retroperitoneal lymph nodes† | 42 | 24 | 14 |
| Peritoneum* | 38 | 21 | 12 |
| Lung or mediastinum | 25 | 14 | 8 |
| Abdominal wall/incision | 8 | 5 | 2 |
| Bone | 3 | 2 | 1 |
| Skin | 1 | 1 | 0 |
| Adrenal gland | 1 | 1 | 0 |
| Axillary or neck lymph nodes | 2 | 1 | 1 |
| Spleen | 1 | 1 | 0 |
| Totals | |||
| Recurrences, no. | 245 | ||
| Patients with a recurrence, n | 177 | 58 | |
| Patients with an intial local recurrence, n | 81 | 26 | |
| Patients with an initial isolated local recurrence, n | 54 | 18 | |
| Patients with an initial distal recurrence, n | 123 | 40 |
Note that patients can have an initial recurrence at more than one site. Consequently, total percentage of recurrence across all sites exceeds 100%.
Includes positive cytology of ascites and omental metastases.
Includes periaortic, pericaval, and celiac artery lymph nodes.